Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma : European Journal of Gastroenterology & Hepatology

Secondary Logo

Journal Logo

Original Articles: Hepatology

Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma

Kim, Yunaa,b; Lee, Jae Seunga,b,c; Lee, Hye Wona,b,c; Kim, Beom Kyunga,b,c; Park, Jun Yonga,b,c; Kim, Do Younga,b,c; Ahn, Sang Hoona,b,c; Goh, Myung Jid; Kang, Wonseokd,e; Kim, Seung Upa,b,c

Author Information
European Journal of Gastroenterology & Hepatology 35(2):p 191-197, February 2023. | DOI: 10.1097/MEG.0000000000002466

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid